Newer antipsychotics no better than older drug in treating child and adolescent schizophrenia
Monday, September 15, 2008 - 04:35
in Health & Medicine
Two newer atypical antipsychotic medications were no more effective than an older conventional antipsychotic in treating child and adolescent schizophrenia and may lead to more metabolic side effects, according to a new study funded by the National Institutes of Health's National Institute of Mental Health (NIMH). The study was published online ahead of print September 15, 2008, in the American Journal of Psychiatry.
Read the whole article on Physorg
More from Physorg
Related
- Newer antipsychotics no better than older drug in treating child and adolescent schizophreniaMon, 15 Sep 2008, 5:36:12 EDT
- First generation antipsychotic drugs as effective as newer ones in some childrenMon, 15 Sep 2008, 5:36:20 EDT
- Combating weight gain caused by antipsychotic treatmentsThu, 26 Mar 2009, 2:44:15 EDT
- Use of antipsychotic medications by children and adolescents associated with significant weight gainTue, 27 Oct 2009, 16:41:41 EDT
- Looking beyond the drug receptor for clues to drug effectivenessMon, 25 Aug 2008, 17:36:46 EDT